The milestone demonstrates AVISE CTD’s value and adoption within the rheumatologic community, clearly demonstrating superior laboratory testing for improved patient…
BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…
Has helped over 24,400 Seniors Age Safely at Home Since Its InceptionDENVER, Dec. 12, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding…
U.S. total addressable market for five initial indications is $25 to $33 billion REMINDER: Business Update Conference Call begins at…
Groundbreaking thinkALS™ Tool Empowers Providers to Identify and Refer Patients Quicker ARLINGTON, Va., Dec. 10, 2024 /PRNewswire/ -- It can take…
Integration agreement secured with Beth Israel Deaconess Medical Center, Boston USA Integration follows successful trial of EchoSolv-AS by Beth Israel…
Milliman MedInsight MSSP ACO clients see higher success rate than nationwide ACOs SEATTLE, Dec. 10, 2024 /PRNewswire/ -- Milliman MedInsight, a…
NEW YORK, Dec. 10, 2024 /PRNewswire/ -- The demand for GLP-1 medications is skyrocketing, with studies predicting the market will…
Successful Medicare Insurance Agency Expands SMS' Eastern U.S. Distribution OMAHA, Neb., Dec. 10, 2024 /PRNewswire/ -- In a quest to…
RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without…